Seaport Therapeutics, Inc. Common Stock

NASDAQ:SPTX

Biotechnology

Healthcare
$18.31 +0.58%

+$0.10 today

Market cap
$980.14M
Beta
0.00
52W Low $14.85High $23.00

Volume 0.68M

Average 0.41M

SPTX EBITDA Margin

EBITDA as a percentage of revenue.

No reported EBITDA Margin figures are available to summarize.

EBITDA Margin history

Percent of revenue · from the income statement

No EBITDA Margin data reported for this period type.

EBITDA Margin vs competitors

How SPTX compares with its peers on the latest reported figures

SPTX Competitors Peer median
EBITDA Margin for SPTX and competitors
Company Period LTM level YoY 3-year change
VNDAVanda Pharmaceuticals Inc.LTM Mar 2026-62.6% -41.0 pp-64.2 pp
RAPPRapport Therapeutics, Inc. Common StockLTM Mar 2026-590.7% ——
SPTXSeaport Therapeutics, Inc. Common Stock—— ——
LBRXLB Pharmaceuticals Inc Common StockFY2025— ——
GHRSGH Research PLCFY2025— ——
CTNMContineum Therapeutics, Inc. Class A Common StockFY2025— ——
MPLTMapLight Therapeutics, Inc.FY2025— ——
NMRANeumora Therapeutics, Inc. Common StockFY2025— ——
Peer median (excluding SPTX) -326.6%-41.0 pp-64.2 pp

Competitors are the stored peer set for SPTX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Seaport Therapeutics, Inc. Common Stock

NASDAQ:SPTX

Intrinsic Alpha fair value

Locked

Current Price

$18.31

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.